1. Home
  2. QNCX vs BRID Comparison

QNCX vs BRID Comparison

Compare QNCX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • BRID
  • Stock Information
  • Founded
  • QNCX 2012
  • BRID 1932
  • Country
  • QNCX United States
  • BRID United States
  • Employees
  • QNCX N/A
  • BRID N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • BRID Specialty Foods
  • Sector
  • QNCX Health Care
  • BRID Consumer Staples
  • Exchange
  • QNCX Nasdaq
  • BRID Nasdaq
  • Market Cap
  • QNCX 62.0M
  • BRID 93.2M
  • IPO Year
  • QNCX 2019
  • BRID N/A
  • Fundamental
  • Price
  • QNCX $1.40
  • BRID $10.31
  • Analyst Decision
  • QNCX Strong Buy
  • BRID
  • Analyst Count
  • QNCX 4
  • BRID 0
  • Target Price
  • QNCX $9.50
  • BRID N/A
  • AVG Volume (30 Days)
  • QNCX 126.6K
  • BRID 1.5K
  • Earning Date
  • QNCX 03-31-2025
  • BRID 03-07-2025
  • Dividend Yield
  • QNCX N/A
  • BRID N/A
  • EPS Growth
  • QNCX N/A
  • BRID N/A
  • EPS
  • QNCX N/A
  • BRID N/A
  • Revenue
  • QNCX N/A
  • BRID $223,645,000.00
  • Revenue This Year
  • QNCX N/A
  • BRID N/A
  • Revenue Next Year
  • QNCX N/A
  • BRID N/A
  • P/E Ratio
  • QNCX N/A
  • BRID N/A
  • Revenue Growth
  • QNCX N/A
  • BRID N/A
  • 52 Week Low
  • QNCX $0.51
  • BRID $7.77
  • 52 Week High
  • QNCX $2.45
  • BRID $14.69
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 36.52
  • BRID 49.20
  • Support Level
  • QNCX $1.38
  • BRID $10.28
  • Resistance Level
  • QNCX $1.49
  • BRID $10.51
  • Average True Range (ATR)
  • QNCX 0.12
  • BRID 0.13
  • MACD
  • QNCX -0.01
  • BRID -0.02
  • Stochastic Oscillator
  • QNCX 7.32
  • BRID 47.50

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.

Share on Social Networks: